New leadership aims to advance psychiatric and addiction research initiatives.
- George Konis, MD, appointed President of Psychiatry and Addiction Research
- Focus on advancing clinical research in mental health
- Konis brings extensive experience in psychiatry and addiction
Evolution Research Group has appointed George Konis, MD, to lead its Psychiatry and Addiction Research division. This leadership change comes as the organization seeks to enhance its focus on psychiatric and addiction research initiatives. Dr. Konis brings significant experience in the fields of psychiatry and addiction treatment, aiming to drive further advancements in these vital areas of healthcare.
In his new role, Dr. Konis will oversee various research programs focused on mental health and substance use disorders. His prior work includes leadership positions in clinical research, with a commitment to improving treatment protocols and outcomes for patients. This appointment is expected to strengthen Evolution Research Group's position in the mental health research landscape.
Dr. Konis holds a wealth of expertise, having worked extensively in both clinical settings and research environments. His background equips him with the insights needed to enhance the organization's strategic direction in addressing the challenges of psychiatric illnesses and addiction.
